icicidirect trading acc.no : 8500566294 demat : IN302902-42015368

multi cap :: 

https://www.valueresearchonline.com/funds/2415/sbi-focused-equity-fund#fund-performance
 best perfomed during 2009 , seems better than axis 25, has pharma in protfolio. 5* , 1% exit load, 1.88 expense

https://www.valueresearchonline.com/funds/14951/axis-focused-25-fund
5*, 1%exit, 1.8% expense, better than avg performance nothing stellar


Multi cap, international :
https://www.valueresearchonline.com/funds/19699/parag-parikh-long-term-equity-fund-regular-plan
5*, 2% - 1yr 1% - 2Yr, 1.9% expense, not a very good performance but has exposure us equity & pharma

small cap ::
https://www.valueresearchonline.com/funds/5069/dsp-small-cap-fund-regular-plan#fund-performance
3*, not very good returns till 5yrs

https://www.valueresearchonline.com/funds/22333/axis-small-cap-fund-regular-plan
4*, 

Health care ::
https://www.valueresearchonline.com/funds/38197/dsp-healthcare-fund-regular-plan
seems better than peers, not a very good performance in the recent past, 1% exit, 2.48% expense
good 1 yr returns, other funds by manager 3* & 4* 

https://www.valueresearchonline.com/funds/2241/nippon-india-pharma-fund#fund-performance
1% 1year, 2.1% exit, performed better in 2008 , but not good after that, seems better than tata . Other funds by manager no rating

https://www.valueresearchonline.com/funds/31350/tata-india-pharma-and-healthcare-fund-regular-plan
0.25% in 90 days, 2.54 expense, seems good stock selection, other funds by manager are 2* & 3*
